AzTrials
AzTrials

Cardiac ArrestPhase 4NCT05173740

Rehabilitation for Survivors of Out-of-hospital Cardiac Arrest

A Phase 4 study testing Individually tailored rehabilitation intervention in people with Cardiac Arrest and Heart Arrest, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a parallel group multicentre investigator-initiated clinical randomised controlled superiority trial that will include a total of 214 survivors of OHCA. Participants will to be randomized with a 1:1 allocation ratio to either a intervention consisting of a comprehensive initiated tailored rehabilitation… Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Individually tailored rehabilitation intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
214 participants
Where
1 siteDenmark
Study dates
1 Feb 2022to 31 Jul 2028
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All adult survivors with first time out-of-hospital cardiac arrest
  • Discharged from the Hospitals will be assessed eligible for inclusion

Who cannot join

  • Survivors who prior to the cardiac arrest were not part of the labour force with at least two years until they are qualified to receive retirement state pensions
  • Patients that cannot understand and fulfil the study surveys (in Danish)
  • Patients with short witnessed cardiac arrests with return of spontaneous circulation estimated less than 4 minutes and immediate awakening without ICU treatment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jan Christensen, PhD contact

35453001

fysjan@gmail.com

Denmark1 site, 1 recruiting
  • Rigshospitalet

    Copenhagen

    Jan Christensen, Senior researcher

    Recruiting

Other trials in Denmark

About this study

Official title: The ROCK Trial. A Multidisciplinary Rehabilitation Intervention Targeted Return-to-work in Sudden Out-of-hospital Cardiac Arrest Survivors A Pragmatic Randomised Controlled Trial

This study is a parallel group multicentre investigator-initiated clinical randomised controlled superiority trial that will include a total of 214 survivors of OHCA.

Participants will to be randomized with a 1:1 allocation ratio to either a intervention consisting of a comprehensive initiated tailored rehabilitation intervention focusing on supporting RTW plus usual care compared to usual care alone.

Read the detailed description

The ROCK trial is a two-arm multicentre investigator-initiated clinical randomised controlled superiority trial evaluating the effectiveness of a comprehensive individually tailored rehabilitation intervention focusing on supporting labour marked participation of survivors of out-of-hospital cardiac arrest compared to usual care, with primary endpoint measured after 12 months follow-up.

The overall aim of the ROCK trial is to evaluate the effectiveness of a comprehensive individually tailored multidisciplinary rehabilitation intervention for survivors of OHCA on RTW compared to usual care. The investigators hypothesize that the intervention will result in a higher-level labour marked attachment one year after hospital discharge in addition to increased health-related quality of life.

A full statistical analysis plan describing all details have been developed. In short, data from the national register on social transfer payments (DREAM database) will form the basis for the primary outcome. The primary outcome is labour market participation, defined as the proportion of employment vs. on social transfer payment, and the primary end point will be collected 12 months after hospital discharge.

Being tested
Individually tailored rehabilitation intervention, Usual care
Keywords
Labour marked, Cardiac arrest, Heart Arrest, Cardiopulmonary Resuscitation, Return to work, Return-to-work, Back to Work, Rehabilitation, Recovery of Function, Cardiac Rehabilitation
Medical subject headings
Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individually tailored rehabilitation interventionOther

    Individually tailored rehabilitation intervention

  • Usual careOther

    Usual care

Study groups in NCT05173740
Study groupRoleWhat they receive
Individually tailored rehabilitation intervention + usual careExperimentalA comprehensive neurocognitive assessment and a thorough individual assessment of rehabilitation needs will be conducted to inform the individually tailored intervention plan. Core intervention elements are: 1) comprehensive assessment of individual rehabilitation needs including neuropsychology tests in order to make a individually tailored intervention plan coordinated with the multidisciplinary rehabilitation team, 2) providing strategies to lessen impact for the individual cognitive impairment, 3) educating survivors and relatives about the impact of a cardiac arrest and consequences on daily life, 4) work preparation, including establishment of routines and opportunities to practice work skills and 5) collaboration with the local municipality's job centre and employers to plan, support and monitor graded RTW, 6) short term therapy by psychologist dealing with thoughts and behaviour in relation to cardiac arrest.
Receives: Other: Individually tailored rehabilitation intervention
Usual careActive comparatorAll participants including those allocated to the usual care group will be seen by an occupational therapist if their MoCA screening score ≤26. Furthermore, if considered relevant by the discharging unit, survivors are referred for rehabilitation provided and delivered in the local municipality where the participant is resident. The content of the rehabilitation will typically be based on the content of the rehabilitation plan from the discharging hospital unit and an individual assessment of the survivors' expressed needs, within the local municipality where the participant is resident.
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Labour market participation using data from the DREAM database

    The primary outcome of the clinical trial is labour market participation, defined as a dichotomized outcome, employment vs. on social transfer payment 12 months after hospital discharge.

    Measured: 12-months after hospital discharge

Secondary outcomes (10)
  1. Return-to-work - Multi-state models of patients change in states from baseline to 12-months after hospital discharge

    3 multi-state models (working full-time, Working part-time, sick leave and the absorbing stated retired). Patients are not very likely to die during follow-up; this state may be superfluous. In the model working hours and retirement to private pensions will need to be assessed using self-reported data.

    Measured: 12-months after hospital discharge

  2. PRO: Readiness for return-to-work (RRTW)

    Readiness for return-to-work (RRTW) consisting of 22 items.

    Measured: 2 weeks, 12 weeks, 26 weeks and 52 weeks after hospital discharge

  3. PRO: Degree of return-to-work

    Single items covering degree of RTW in hours weekly (compared to prior to the cardiac arrest), job describtion (changed Y/N) and job modification (changes Y/N).

    Measured: 2 weeks, 12 weeks, 26 weeks and 52 weeks after hospital discharge

  4. PROM: EQ-5D-5L

    The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.

    The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflect the patient's own judgement.

    Measured: Baseline (Hospital discharge), 2 weeks, 12 weeks, 26 weeks and 52 weeks after hospital discharge

  5. PROM: Multidimensional fatigue inventory (MFI-20)

    The MFI is a 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: general fatigue, physical fatigue, reduced activity, reduced motivation and mental fatigue.

    Measured: Baseline (Hospital discharge), 2 weeks, 12 weeks, 26 weeks and 52 weeks after hospital discharge

  6. PROM: The Hospital Anxiety and Depression Scale (HADS)

    The questionnaire comprises seven questions for anxiety and seven questions for depression

    Measured: Baseline (Hospital discharge), 2 weeks, 12 weeks, 26 weeks and 52 weeks after hospital discharge

  7. PROM: The Pittsburgh Sleep Quality Index (PSQI)

    The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score

    Measured: Baseline (Hospital discharge), 2 weeks, 12 weeks, 26 weeks and 52 weeks after hospital discharge

  8. The Health Literacy Questionnaire (HLQ)

    HLQ has nine scales that each measure an aspect of the multidimensional construct of health literacy.

    Measured: 2 weeks, 26 weeks and 52 weeks after hospital discharge

  9. PROM: Disease specific health-related quality of life (HeartQoL)

    The HeartQoL questionnaire comprises 14-items forming a physical, emotional subscales and a global score,

    Measured: 2 weeks, 12 weeks, 26 weeks and 52 weeks after hospital discharge

  10. The Impact of Event Scale - Revised (IES-R)

    The Impact of Event Scale - Revised (IES-R) measures syptoms related to post-traumatic stress disorder (PTSD) The IES-R has 22 questions, that comprises a total subjective stress scale and three subscales (Intrusion, Avoidance, Hyperarousal)

    Measured: 12 weeks, 26 weeks and 52 weeks after hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2021
  2. Study start1 Feb 2022
  3. Primary completion31 Jul 2027 (estimated)
  4. Study completion31 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
214 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05173740
Sponsor's protocol ID
H-20049654
Status last verified
Dec 2025
First submitted
27 Nov 2021
Last updated
8 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: By contacting the corresponding author and upon reasonable request, de-identified data can be made available for individual participant data meta-analysis.

Publications

  • Christensen J, Winkel BG, Kirkeskov L, Folke F, Winther-Jensen M, Eckhardt-Bentsen C, Kjaergaard J, Hassager C, Wagner MK. The ROCK trial-a multidisciplinary Rehabilitation intervention for sudden Out-of-hospital Cardiac arrest survivors focusing on return-to-worK: a pragmatic randomized controlled trial protocol. Trials. 2024 Feb 1;25(1):99. doi: 10.1186/s13063-024-07911-6.

    PubMed 38303019

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Individually tailored rehabilitation intervention in people with Cardiac Arrest and Heart Arrest, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jan Christensen, PhD (35453001, fysjan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Labour market participation using data from the DREAM database (time frame: 12-months after hospital discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05173740, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in